EFPIA - NEWSLETTER

EFPIA Newsletter 16 November 2017

#WeWontRest

UP TO 3 MILLION DEATHS ARE AVOIDED EACH YEAR THANKS TO VACCINES

Disease never stops, so neither do we. Medical innovation needs to be one step ahead so that breakthroughs can be made. And we won't rest until we've helped make the world a healthier place for everyone.

#WeWontRest

News

13 November 2017 13112017 EFPIA DG reiterates the importance of putting patients at the centre of the EMA relocation...

Nathalie Moll underlines the importance that this decision is made on the basis of essential and objective criteria...

13 November 2017 13112017 EFPIA Welcomes the Review Report Directive 2010/63/EU and Stresses the Importance...

The pharmaceutical industry together with its research partners is investing significant efforts to fully integrate...

16 November 2017 16112017 EFPIA and its Specialised Groups Reiterate their Commitment to Tackling AMR

Only a collaborative approach will allow us to make significant inroad in the many common areas, including pharmaceuticals...

Blogs

14 November 2017 14112017 Collaboration: The key to diabetes

A blog by Dr. Elias Zerhouni, President R&D, Sanofi

10 November 2017 10112017 Incentives, IP and smaller companies – the story of Chiesi and Holostem

IP rights and EU pharmaceutical incentives enable ongoing innovation for patients

Videos

EFPIA President Dr. Stefan Oschmann makes a video pledge for the European Antibiotic Awareness Day 2017

Tackling AMR requires collaboration between all stakeholders: governments, human and animal health industries, healthcare professionals, environmental experts, farmers and patients. Only through concerted action will we find solutions: In other words, a “One Health” approach.

Vaccines Europe President Pascale Mauran makes a video pledge for the European Antibiotic Awareness Day 2017

Being vaccinated reduces the potential misuse of antibiotics by preventing viral diseases for which antibiotics are inappropriately prescribed

What we are reading

EU health Commissioner Vytenis Andriukaitis discusses Europe’s superbug battlefront 13 November 2017 (EurActiv)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶